Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 134-140

Spandidos Publications

Access to resources Recommend Favorite

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Zhang Jian   Zhang Weiqing   Huang Shaohong   Li Hui   Li Yun   Chen Huiguo   Wu Weibing   Zhou Wei   Wang Cuiping   Liao Hongying   Gu Lijia  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-11 ,pp. : 849-858

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

By Jiang Jingwei   Huang Lizhen   Liang Xiaohua   Zhou Xinli   Huang Ruofan   Chu Zhaohui   Zhan Qiong  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 582-588

Informa Healthcare

Access to resources Recommend Favorite

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

By  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1133-1133

Oxford University Press

Access to resources Recommend Favorite

Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials

By Valachis A.   Polyzos N.   Patsopoulos N.   Georgoulias V.   Mavroudis D.   Mauri D.  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite